{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:33:16Z","timestamp":1769553196299,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/npp.2013.61","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T16:37:28Z","timestamp":1362501448000},"page":"1648-1654","source":"Crossref","is-referenced-by-count":33,"title":["Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide\u2014A 3T-MRS Study in Healthy Subjects"],"prefix":"10.1038","volume":"38","author":[{"given":"Peter","family":"Zwanzger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Zavorotnyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gencheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Diemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Kugel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Heindel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tillmann","family":"Ruland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Ohrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"BFnpp201361_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.02.005","volume":"172","author":"PD Arnold","year":"2009","unstructured":"Arnold PD, MacMaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E et al (2009). Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res 172: 136\u2013139.","journal-title":"Psychiatry Res"},{"key":"BFnpp201361_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","volume":"47","author":"DP Auer","year":"2000","unstructured":"Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000). Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47: 305\u2013313.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201361_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","volume":"45","author":"JC Ballenger","year":"1988","unstructured":"Ballenger JC, Burrows GD, DuPont RL Jr., Lesser IM, Noyes R Jr., Pecknold JC et al (1988). Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 45: 413\u2013422.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0924-977X(03)00100-7","volume":"14","author":"V Bergink","year":"2004","unstructured":"Bergink V, van Megen HJ, Westenberg HG (2004). Glutamate and anxiety. Eur Neuropsychopharmacol 14: 175\u2013183.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp201361_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000). Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351\u2013354.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201361_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.neubiorev.2009.05.009","volume":"33","author":"MM Blanchard","year":"2009","unstructured":"Blanchard MM, Mendelsohn D, Stamp JA (2009). The HR\/LR model: further evidence as an animal model of sensation seeking. Neurosci Biobehav Rev 33: 1145\u20131154.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201361_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31\u201339.","journal-title":"Nature"},{"key":"BFnpp201361_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/ajp.151.2.261","volume":"151","author":"J Bradwejn","year":"1994","unstructured":"Bradwejn J, Koszycki D (1994). Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151: 261\u2013263.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201361_CR9","first-page":"678","volume":"18","author":"DW Brann","year":"1997","unstructured":"Brann DW, Mahesh VB (1997). Excitatory amino acids: evidence for a role in the control of reproduction and anterior pituitary hormone secretion. Endocr Rev 18: 678\u2013700.","journal-title":"Endocr Rev"},{"key":"BFnpp201361_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-642-68962-8","volume-title":"Cortex Cerebri","author":"OD Creutzfeldt","year":"1983","unstructured":"Creutzfeldt OD (1983). Abgrenzung von Hirnarealen aufgrund cytoarchitektonischer Unterschiede. In: Creutzfeldt OD, (eds) Cortex Cerebri. Springer: Berlin, Heidelberg, Germany; New York, USA. pp 47\u201357."},{"key":"BFnpp201361_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","volume":"20","author":"DJ Dillon","year":"1987","unstructured":"Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF (1987). Measurement of lactate-induced panic and anxiety. Psychiatry Res 20: 97\u2013105.","journal-title":"Psychiatry Res"},{"key":"BFnpp201361_CR12","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.2174\/138161208786848784","volume":"14","author":"K Domschke","year":"2008","unstructured":"Domschke K, Zwanzger P (2008). GABAergic and endocannabinoid dysfunction in anxiety\u2014future therapeutic targets? Curr Pharm Des 14: 3508\u20133517.","journal-title":"Curr Pharm Des"},{"key":"BFnpp201361_CR13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.npp.1300572","volume":"30","author":"D Eser","year":"2005","unstructured":"Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schule C et al (2005). Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. Neuropsychopharmacology 30: 192\u2013195.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201361_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hbm.20522","volume":"30","author":"D Eser","year":"2009","unstructured":"Eser D, Leicht G, Lutz J, Wenninger S, Kirsch V, Schule C et al (2009). Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. Hum Brain Mapp 30: 511\u2013522.","journal-title":"Hum Brain Mapp"},{"key":"BFnpp201361_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuroimage.2006.10.004","volume":"34","author":"J Gallinat","year":"2007","unstructured":"Gallinat J, Kunz D, Lang UE, Neu P, Kassim N, Kienast T et al (2007). Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. Neuroimage 34: 671\u2013678.","journal-title":"Neuroimage"},{"key":"BFnpp201361_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","volume":"58","author":"AW Goddard","year":"2001","unstructured":"Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OA et al (2001). Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 58: 556\u2013561.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","volume":"157","author":"JM Gorman","year":"2000","unstructured":"Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000). Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157: 493\u2013505.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201361_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/sj.mp.4000778","volume":"5","author":"ID Grachev","year":"2000","unstructured":"Grachev ID, Apkarian AV (2000). Anxiety in healthy humans is associated with orbital frontal chemistry. Mol Psychiatry 5: 482\u2013488.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201361_CR19","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archpsyc.65.10.1166","volume":"65","author":"G Hasler","year":"2008","unstructured":"Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC (2008). Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 65: 1166\u20131175.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1176\/appi.ajp.2010.09070994","volume":"167","author":"G Hasler","year":"2010","unstructured":"Hasler G, van der Veen JW, Grillon C, Drevets WC, Shen J (2010). Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 167: 1226\u20131231.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201361_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/1096-9861(20000703)422:3<352::AID-CNE3>3.0.CO;2-F","volume":"422","author":"JP Herman","year":"2000","unstructured":"Herman JP, Eyigor O, Ziegler DR, Jennes L (2000). Expression of ionotropic glutamate receptor subunit mRNAs in the hypothalamic paraventricular nucleus of the rat. J Comp Neurol 422: 352\u2013362.","journal-title":"J Comp Neurol"},{"key":"BFnpp201361_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/archgenpsychiatry.2010.93","volume":"67","author":"M Hoerst","year":"2010","unstructured":"Hoerst M, Weber-Fahr W, Tunc-Skarka N, Ruf M, Bohus M, Schmahl C et al (2010). Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls. Arch Gen Psychiatry 67: 946\u2013954.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pbb.2011.01.009","volume":"99","author":"GB Kaplan","year":"2011","unstructured":"Kaplan GB, Moore KA (2011). The use of cognitive enhancers in animal models of fear extinction. Pharmacol Biochem Behav 99: 217\u2013228.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201361_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0006-3223(99)00118-3","volume":"47","author":"M Kellner","year":"2000","unstructured":"Kellner M, Wiedemann K, Yassouridis A, Levengood R, Guo LS, Holsboer F et al (2000). Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry 47: 107\u2013111.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201361_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/archpsyc.55.9.801","volume":"55","author":"RC Kessler","year":"1998","unstructured":"Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE (1998). Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 55: 801\u2013808.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","volume":"8","author":"D Koszycki","year":"1998","unstructured":"Koszycki D, Zacharko RM, Le Melledo JM, Bradwejn J (1998). Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety 8: 1\u20137.","journal-title":"Depress Anxiety"},{"key":"BFnpp201361_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/11533230-000000000-00000","volume":"24","author":"JH Krystal","year":"2010","unstructured":"Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS (2010). Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24: 669\u2013693.","journal-title":"CNS Drugs"},{"key":"BFnpp201361_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.biopsych.2012.09.004","volume":"73","author":"G Leicht","year":"2013","unstructured":"Leicht G, Mulert C, Eser D, S\u00e4mann PG, Ertl M, Laenger A et al (2013). Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans. Biol Psychiatry 73: 337\u2013344.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201361_CR29","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.neuroimage.2011.05.048","volume":"57","author":"RJ Maddock","year":"2011","unstructured":"Maddock RJ, Casazza GA, Buonocore MH, Tanase C (2011). Vigorous exercise increases brain lactate and Glx (glutamate+glutamine): a dynamic 1H-MRS study. Neuroimage 57: 1324\u20131330.","journal-title":"Neuroimage"},{"key":"BFnpp201361_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","volume":"55","author":"AL Malizia","year":"1998","unstructured":"Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998). Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 55: 715\u2013720.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cll.2010.07.006","volume":"30","author":"EI Martin","year":"2010","unstructured":"Martin EI, Ressler KJ, Binder E, Nemeroff CB (2010). The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clin Lab Med 30: 865\u2013891.","journal-title":"Clin Lab Med"},{"key":"BFnpp201361_CR32","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.pnpbp.2011.05.006","volume":"35","author":"Y Mashhoon","year":"2011","unstructured":"Mashhoon Y, Janes AC, Jensen JE, Prescot AP, Pachas G, Renshaw PF et al (2011). Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome. Prog Neuropsychopharmacol Biol Psychiatry 35: 1709\u20131713.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp201361_CR33","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1176\/appi.ajp.162.12.2379","volume":"162","author":"SJ Mathew","year":"2005","unstructured":"Mathew SJ, Amiel JM, Coplan JD, Fitterling HA, Sackeim HA, Gorman JM (2005). Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry 162: 2379\u20132381.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"BFnpp201361_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00406-012-0352-5","volume":"262","author":"C Nothdurfter","year":"2012","unstructured":"Nothdurfter C, Baghai TC, Sch\u00fcle C, Rupprecht R (2012). Translocator protein (18\u2009kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders. Eur Arch Psychiatry Clin Neurosci 262 (Suppl 2): 107\u2013112.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp201361_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","volume":"67","author":"MW Otto","year":"2010","unstructured":"Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA et al (2010). Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry 67: 365\u2013370.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201361_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0925-4927(03)00003-9","volume":"122","author":"B Pfleiderer","year":"2003","unstructured":"Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Homann U, Wolgast M et al (2003). Effective electroconvulsive therapy reverses glutamate\/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatr Res Neuroimaging 122: 185\u2013192.","journal-title":"Psychiatr Res Neuroimaging"},{"key":"BFnpp201361_CR37","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1006\/nimg.2002.1308","volume":"17","author":"B Pfleiderer","year":"2002","unstructured":"Pfleiderer B, Ostermann J, Michael N, Heindel W (2002). Visualization of auditory habituation by fMRI. Neuroimage 17: 1705\u20131710.","journal-title":"Neuroimage"},{"key":"BFnpp201361_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00001756-200502080-00024","volume":"16","author":"KL Phan","year":"2005","unstructured":"Phan KL, Fitzgerald DA, Cortese BM, Seraji-Bozorgzad N, Tancer ME, Moore GJ (2005). Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport 16: 183\u2013186.","journal-title":"Neuroreport"},{"key":"BFnpp201361_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00023210-200822090-00004","volume":"22","author":"C Pittenger","year":"2008","unstructured":"Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G (2008). Riluzole in the treatment of mood and anxiety disorders. CNS Drugs 22: 761\u2013786.","journal-title":"CNS Drugs"},{"key":"BFnpp201361_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mrm.1910300604","volume":"30","author":"SW Provencher","year":"1993","unstructured":"Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672\u2013679.","journal-title":"Magn Reson Med"},{"key":"BFnpp201361_CR41","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","volume":"61","author":"KJ Ressler","year":"2004","unstructured":"Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E et al (2004). Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136\u20131144.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR42","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.pbb.2011.04.010","volume":"100","author":"C Riaza Bermudo-Soriano","year":"2011","unstructured":"Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E (2011). New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 100: 752\u2013774.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201361_CR43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/37601","volume":"390","author":"MT Rogan","year":"1997","unstructured":"Rogan MT, Staubli UV, LeDoux JE (1997). Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604\u2013607.","journal-title":"Nature"},{"key":"BFnpp201361_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/bjp.176.3.229","volume":"176","author":"PP Roy-Byrne","year":"2000","unstructured":"Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC (2000). Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry 176: 229\u2013235.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201361_CR45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N et al (2010). Translocator protein (18\u2009kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9: 971\u2013988.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp201361_CR46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1175055","volume":"325","author":"R Rupprecht","year":"2009","unstructured":"Rupprecht R, Rammes G, Eser D, Baghai TC, Sch\u00fcle C, Nothdurfter C et al (2009). Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325: 490\u2013493.","journal-title":"Science"},{"key":"BFnpp201361_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0301-0082(95)00047-X","volume":"48","author":"TE Salt","year":"1996","unstructured":"Salt TE, Eaton SA (1996). Functions of ionotropic and metabotropic glutamate receptors in sensory transmission in the mammalian thalamus. Prog Neurobiol 48: 55\u201372.","journal-title":"Prog Neurobiol"},{"key":"BFnpp201361_CR48","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","volume":"56","author":"G Sanacora","year":"1999","unstructured":"Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56: 1043\u20131047.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.neuroimage.2006.01.035","volume":"31","author":"T Schunck","year":"2006","unstructured":"Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y et al (2006). Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage 31: 1197\u20131208.","journal-title":"Neuroimage"},{"key":"BFnpp201361_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","volume":"12","author":"DV Sheehan","year":"1997","unstructured":"Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara LI et al (1997). Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. Eur Psychiatry 12: 232\u2013241.","journal-title":"Eur Psychiatry"},{"key":"BFnpp201361_CR51","first-page":"332","volume":"22","author":"J Shlik","year":"1997","unstructured":"Shlik J, Aluoja A, Vasar V, Vasar E, Podar T, Bradwejn J (1997). Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22: 332\u2013340.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp201361_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","volume":"60","author":"A Strohle","year":"2003","unstructured":"Strohle A, Romeo E, di Michele F, Pasini A, Hermann B, Gajewsky G et al (2003). Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry 60: 161\u2013168.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201361_CR53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","volume":"159","author":"A Strohle","year":"2002","unstructured":"Strohle A, Romeo E, Di Michele F, Pasini A, Yassouridis A, Holsboer F et al (2002). GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 159: 145\u2013147.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201361_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/BF00589901","volume":"99","author":"JM Stutzmann","year":"1989","unstructured":"Stutzmann JM, Cintrat P, Laduron PM, Blanchard JC (1989). Riluzole antagonizes the anxiogenic properties of the beta-carboline FG 7142 in rats. Psychopharmacology (Berl) 99: 515\u2013519.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201361_CR55","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0091-3057(01)00698-0","volume":"71","author":"DL Walker","year":"2002","unstructured":"Walker DL, Davis M (2002). The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 71: 379\u2013392.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201361_CR56","first-page":"328","volume-title":"Anxiety and its Disorders","author":"KS White","year":"2002","unstructured":"White KS, Barlow DH (2002). Panic disorder and agoraphobia. In: Barlow DH, (eds) Anxiety and its Disorders. The Guilford Press: New York, London, UK. pp 328\u2013379."},{"key":"BFnpp201361_CR57","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/da.21919","volume":"29","author":"P Zwanzger","year":"2012","unstructured":"Zwanzger P, Domschke K, Bradwejn J (2012). Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. Depress Anxiety 29: 762\u2013774.","journal-title":"Depress Anxiety"},{"key":"BFnpp201361_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.npp.1300131","volume":"28","author":"P Zwanzger","year":"2003","unstructured":"Zwanzger P, Eser D, Aicher S, Schule C, Baghai TC, Padberg F et al (2003). Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology 28: 979\u2013984.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201361_CR59","first-page":"167","volume":"30","author":"P Zwanzger","year":"2005","unstructured":"Zwanzger P, Rupprecht R (2005). Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. J Psychiatry Neurosci 30: 167\u2013175.","journal-title":"J Psychiatry Neurosci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201361","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:18Z","timestamp":1684453638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnpp201361"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.61","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}